The upregulation of IL-2 and downstream immune cytokine GM-CSF induced by the knockdown of E2F6 indicated that the immunosuppressive effect of TAC was weakened, which further validated that E2F6 acted as a repressor of PPP3R1, then inhibited the downstream immune activation of TAC. The gene discussed is CSF2; the disease is persistent truncus arteriosus.